LifeSci Venture Partners
250 West 55th Street, 34th Floor, New York, NY, 10019, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Serapha Bio | Jun 2026Participated | $138 MSeries A | |
Veradermics | Oct 2025Participated | $150 MSeries C | |
Biolinq | Apr 2025Participated | $100 MSeries C | |
Candid Therapeutics | Sep 2024Participated | $370 MOther Equity | |
Averto Medical | May 2024Participated | $30 MSeries A | |
ProfoundBio | Feb 2024Participated | $112 MSeries B | |
MOMA Therapeutics | May 2022Participated | $150 MSeries B | |
Beta Bionics | Feb 2022Participated | $57 MSeries C | |
Ceptur Therapeutics | Jan 2022Participated | $75 MSeries A | |
Clade Therapeutics | Nov 2021Participated | $87 MSeries A | |
Antios Therapeutics | Nov 2021Participated | $75 MSeries B | |
RayzeBio | Jun 2021Participated | $108 MSeries C | |
Serapha Bio | Jun 2026Participated | $138 MSeries A | |
Veradermics | Oct 2025Participated | $150 MSeries C | |
Biolinq | Apr 2025Participated | $100 MSeries C | |
Candid Therapeutics | Sep 2024Participated | $370 MOther Equity | |
Averto Medical | May 2024Participated | $30 MSeries A | |
ProfoundBio | Feb 2024Participated | $112 MSeries B | |
MOMA Therapeutics | May 2022Participated | $150 MSeries B | |
Beta Bionics | Feb 2022Participated | $57 MSeries C | |
Ceptur Therapeutics | Jan 2022Participated | $75 MSeries A | |
Clade Therapeutics | Nov 2021Participated | $87 MSeries A | |
Antios Therapeutics | Nov 2021Participated | $75 MSeries B | |
RayzeBio | Jun 2021Participated | $108 MSeries C |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 1 | 7 |
| Series B | 1 | 13 |
| Series C+ | 0 | 8 |
| Other Equity | 0 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Nov '17 | 1 |
| Dec '17 | 1 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 0 |
| Jun '18 | 1 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 1 |
| Jan '19 | 1 |
| Feb '19 | 0 |
| Mar '19 | 1 |
| Apr '19 | 0 |
| May '19 | 1 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 1 |
| May '20 | 0 |
| Jun '20 | 1 |
| Jul '20 | 0 |
| Aug '20 | 1 |
| Sep '20 | 1 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 1 |
| Jan '21 | 2 |
| Feb '21 | 1 |
| Mar '21 | 4 |
| Apr '21 | 1 |
| May '21 | 0 |
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 0 |
| Oct '21 | 0 |
| Nov '21 | 2 |
| Dec '21 | 0 |
| Jan '22 | 1 |
| Feb '22 | 1 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 1 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 1 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 32 |
| Hardware & Robotics | 5 |
| Space & Frontier Tech | 2 |
| Enterprise Software | 1 |
| Manufacturing | 1 |
| Consumer & Lifestyle | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 1 |
| $5M-$10M | 0 |
| $10M-$25M | 4 |
| $25M-$50M | 4 |
| $50M-$100M | 8 |
| $100M-$250M | 13 |
| $250M-$500M | 2 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 1 of 1 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 32 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Cormorant Asset Management | 8 |
| Janus Henderson Investors | 8 |
| Logos Capital | 7 |
| Venrock | 7 |
| RA Capital Management | 6 |
| Redmile Group | 6 |
| Samsara BioCapital | 6 |
| Boxer Capital | 5 |
| Invus | 5 |
| RTW Investments | 5 |
| venBio Partners | 5 |
| Alexandria Venture Investments | 4 |
| OrbiMed | 4 |
| Perceptive Advisors | 4 |
| Rock Springs Capital | 4 |
| Soleus Capital | 4 |
| Surveyor Capital | 4 |
| Viking Global Investors | 4 |
| Adage Capital Management | 3 |
| BVF Partners | 3 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 2 | 6% |
| Participating | 30 | 94% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 1 | 50% |
| Co-led | 1 | 50% |
Team
Consulting CFO
Founding Partner&CEO
CMO
Managing Director